News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
672,877 Results
Type
Article (64703)
Company Profile (201)
Press Release (607973)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (180750)
Career Advice (2798)
Deals (33628)
Drug Delivery (106)
Drug Development (79578)
Employer Resources (152)
FDA (15517)
Job Trends (14739)
News (317331)
Policy (30956)
Tag
Academia (2944)
Academic (2)
Accelerated approval (6)
Adcomms (23)
Allergies (90)
Alliances (45334)
ALS (91)
Alzheimer's disease (1366)
Antibody-drug conjugate (ADC) (119)
Approvals (15524)
Artificial intelligence (271)
Autoimmune disease (24)
Automation (16)
Bankruptcy (298)
Best Places to Work (11674)
BIOSECURE Act (19)
Biosimilars (103)
Biotechnology (149)
Bladder cancer (78)
Brain cancer (30)
Breast cancer (278)
Cancer (2242)
Cardiovascular disease (179)
Career advice (2372)
Career pathing (33)
CAR-T (159)
Cell therapy (441)
Cervical cancer (20)
Clinical research (64618)
Collaboration (829)
Company closure (1)
Compensation (390)
Complete response letters (24)
COVID-19 (2669)
CRISPR (46)
C-suite (261)
Cystic fibrosis (105)
Data (2198)
Decentralized trials (2)
Denatured (30)
Depression (44)
Diabetes (276)
Diagnostics (6339)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (125)
Drug pricing (105)
Drug shortages (27)
Duchenne muscular dystrophy (86)
Earnings (63839)
Editorial (42)
Employer branding (18)
Employer resources (134)
Events (100782)
Executive appointments (763)
FDA (16800)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (761)
Gene editing (114)
Generative AI (23)
Gene therapy (321)
GLP-1 (746)
Government (4652)
Grass and pollen (6)
Guidances (65)
Healthcare (19078)
Huntington's disease (21)
IgA nephropathy (28)
Immunology and inflammation (116)
Indications (30)
Infectious disease (2812)
Inflammatory bowel disease (145)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (99)
Interviews (536)
IPO (15557)
IRA (40)
Job creations (3526)
Job search strategy (1994)
Kidney cancer (10)
Labor market (31)
Layoffs (514)
Leadership (22)
Legal (6956)
Liver cancer (72)
Lung cancer (314)
Lymphoma (150)
Machine learning (7)
Management (54)
Manufacturing (303)
MASH (64)
Medical device (12862)
Medtech (12867)
Mergers & acquisitions (18669)
Metabolic disorders (695)
Multiple sclerosis (81)
NASH (17)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1907)
NextGen: Class of 2025 (6683)
Non-profit (4591)
Now hiring (17)
Obesity (366)
Opinion (244)
Ovarian cancer (72)
Pain (94)
Pancreatic cancer (81)
Parkinson's disease (143)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (51)
People (60322)
Pharmaceutical (46)
Pharmacy benefit managers (16)
Phase I (20156)
Phase II (28333)
Phase III (21092)
Pipeline (1179)
Policy (137)
Postmarket research (2711)
Preclinical (8668)
Press Release (67)
Prostate cancer (110)
Psychedelics (30)
Radiopharmaceuticals (261)
Rare diseases (382)
Real estate (6126)
Recruiting (62)
Regulatory (21479)
Reports (33)
Research institute (2483)
Resumes & cover letters (414)
Rett syndrome (5)
RNA editing (4)
RSV (40)
Schizophrenia (73)
Series A (134)
Series B (87)
Service/supplier (9)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3468)
State (1)
Stomach cancer (11)
Supply chain (60)
Tariffs (36)
The Weekly (41)
Vaccines (698)
Venture capitalists (39)
Weight loss (241)
Women's health (34)
Worklife (19)
Date
Today (122)
Last 7 days (855)
Last 30 days (2545)
Last 365 days (31893)
2025 (10528)
2024 (33985)
2023 (38206)
2022 (48763)
2021 (53608)
2020 (52631)
2019 (46529)
2018 (35415)
2017 (31975)
2016 (31457)
2015 (36825)
2014 (29666)
2013 (26257)
2012 (27565)
2011 (27727)
2010 (26027)
Location
Africa (928)
Alabama (56)
Alaska (6)
Arizona (178)
Arkansas (14)
Asia (40144)
Australia (7097)
California (5789)
Canada (1894)
China (512)
Colorado (253)
Connecticut (280)
Delaware (143)
Europe (92673)
Florida (888)
Georgia (205)
Idaho (58)
Illinois (576)
India (25)
Indiana (308)
Iowa (10)
Japan (162)
Kansas (97)
Kentucky (25)
Louisiana (11)
Maine (61)
Maryland (854)
Massachusetts (4334)
Michigan (224)
Minnesota (340)
Mississippi (2)
Missouri (87)
Montana (30)
Nebraska (23)
Nevada (58)
New Hampshire (61)
New Jersey (1692)
New Mexico (29)
New York (1686)
North Carolina (994)
North Dakota (9)
Northern California (2495)
Ohio (195)
Oklahoma (15)
Oregon (37)
Pennsylvania (1293)
Puerto Rico (12)
Rhode Island (31)
South America (1233)
South Carolina (17)
South Dakota (1)
Southern California (2197)
Tennessee (96)
Texas (880)
United States (22214)
Utah (180)
Virginia (148)
Washington D.C. (57)
Washington State (553)
West Virginia (3)
Wisconsin (64)
672,877 Results for "northwestern university feinberg school of medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palvella Therapeutics Announces QTORIN™ Rapamycin 3.9% Anhydrous Gel for the Treatment of Microcystic Lymphatic Malformations Featured in Oral Presentation by Amy Paller, M.S., M.D., Chair of Dermatology at Northwestern University’s Feinberg School of Medicine, at the 15th World Congress of Pediatric Dermatology
April 14, 2025
·
9 min read
Press Releases
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
April 11, 2025
·
7 min read
Press Releases
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
February 24, 2025
·
5 min read
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
April 10, 2025
·
5 min read
Press Releases
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health
April 8, 2025
·
10 min read
Press Releases
LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
February 25, 2025
·
4 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Business
Northwestern Medicine Taps Douglas R. Johnston, MD, to Lead Cardiac Surgery
Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
October 13, 2022
·
4 min read
Press Releases
Preprint from Northwestern University Highlights Complementary Proteomic Analysis of Interleukin-6 Using Next-Generation Protein Sequencing™ and Mass Spectrometry
February 12, 2025
·
5 min read
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University of Colorado School of Medicine.
March 26, 2024
·
4 min read
1 of 67,288
Next
